How should BiPAP (bilevel positive airway pressure) settings be adjusted to correct respiratory acidosis?

Adjusting BiPAP Settings for Respiratory Acidosis

Increase IPAP (inspiratory positive airway pressure) in increments of 2-4 cm H₂O to augment tidal volume and reduce CO₂, while maintaining EPAP to prevent airway collapse and atelectasis. The goal is to correct acidosis to pH >7.2-7.35, not necessarily to normalize CO₂ completely 1, 2.

Initial BiPAP Settings Framework

Start with these baseline parameters and titrate based on the underlying cause:

For Obstructive Disease (COPD/Asthma)

• IPAP: 10-15 cm H₂O
• EPAP: 4-5 cm H₂O
• Respiratory rate: 10-15 breaths/min
• I:E ratio: 1:2 to 1:4 (prolonged expiratory time to prevent gas trapping) 1

For Neuromuscular Disease/Chest Wall Deformity

• IPAP: 10-20 cm H₂O (may need higher pressures for chest wall deformity)
• EPAP: 4-5 cm H₂O
• Respiratory rate: 15-25 breaths/min
• I:E ratio: 1:1 to 1:2 1

Stepwise Adjustment Algorithm

Step 1: Assess Severity of Acidosis

• Mild acidosis (pH 7.30-7.35): Increase IPAP by 2 cm H₂O increments
• Moderate acidosis (pH 7.25-7.30): Increase IPAP by 2-4 cm H₂O increments 2
• Severe acidosis (pH <7.25): More aggressive IPAP increases (4 cm H₂O), but consider invasive ventilation if pH <7.20 despite maximal NIV 1, 2

Step 2: Titrate IPAP to Improve Ventilation

The IPAP-EPAP difference (pressure support) determines tidal volume and CO₂ clearance:

• Target tidal volume: 6-8 mL/kg ideal body weight 1
• Increase IPAP until you achieve adequate chest rise and improved minute ventilation
• Monitor for patient comfort and synchrony with the ventilator
• Maximum IPAP: Generally 20-25 cm H₂O for comfort; higher pressures increase intolerance 3

Step 3: Optimize EPAP

• Maintain EPAP at 4-5 cm H₂O initially
• In obstructive disease with intrinsic PEEP (auto-PEEP), consider increasing EPAP to 5-8 cm H₂O to counterbalance intrinsic PEEP and reduce work of breathing 1
• Critical caveat: Setting EPAP above intrinsic PEEP levels can worsen hyperinflation and is deleterious 1

Step 4: Adjust Backup Rate if Needed

• If patient has inadequate respiratory drive, increase backup respiratory rate by 2-4 breaths/min
• Ensure the rate doesn't cause patient-ventilator dyssynchrony

Target Goals and Permissive Hypercapnia

Do not attempt to rapidly normalize CO₂—this is unnecessary and potentially harmful 1. The evidence-based targets are:

• pH target: 7.25-7.35 (permissive hypercapnia is acceptable if pH >7.20) 1, 2
• SaO₂ target: 88-92% for COPD (>96% for asthma) 1
• In chronic hypercapnia, the higher the baseline CO₂ (inferred by elevated bicarbonate), the higher your target CO₂ should be 1

Common Pitfalls to Avoid

1. Excessive IPAP causing barotrauma: Peak airway pressures >30 cm H₂O increase risk of pneumothorax and hemodynamic compromise from impeded venous return 1

2. Inadequate expiratory time in obstructive disease: This causes dynamic hyperinflation, worsening gas trapping and potentially cardiovascular collapse. Always maintain prolonged expiratory phase 1

3. Using sodium bicarbonate: There is no evidence supporting bicarbonate administration for respiratory acidosis, and it may worsen CO₂ production and negate benefits of permissive hypercapnia 4. Treat the ventilation problem, not with alkali.

4. Poor mask fit: Air leaks reduce effective pressure delivery. Ensure proper mask seal and patient tolerance 5

5. Delayed application: Early BiPAP application (within 1 hour) significantly reduces treatment time and prevents deterioration 6. Don't delay initiation while "optimizing" other therapies.

Monitoring Response

Reassess arterial blood gas after 30-60 minutes of stable settings 5:

• If pH improving but still <7.25: Continue increasing IPAP by 2 cm H₂O
• If no improvement after maximal settings (IPAP 20-25 cm H₂O): Consider invasive mechanical ventilation
• If patient intolerant despite appropriate settings: May need sedation or intubation

Success is defined by: (1) improved ABG parameters, (2) decreased dyspnea and respiratory distress, and (3) avoidance of intubation 5. In COPD exacerbations with respiratory acidosis, BiPAP reduces intubation rates from 27% to 11% and mortality from 20% to 10% when applied appropriately 2.